Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy
出版年份 2018 全文链接
标题
Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-12-18
DOI
10.3389/fonc.2018.00635
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
- (2018) Rene Baudrand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide
- (2018) Masaki Shiota et al. PROSTATE
- Current treatment strategies for advanced prostate cancer
- (2017) Kazumasa Komura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress
- (2016) M. Shiota et al. ANNALS OF ONCOLOGY
- Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer
- (2016) Masaki Shiota et al. INTERNATIONAL JOURNAL OF UROLOGY
- Obesity, hypertension and aldosterone: is leptin the link?
- (2016) Ding Xie et al. JOURNAL OF ENDOCRINOLOGY
- Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7
- (2016) Masaki Shiota et al. JNCI-Journal of the National Cancer Institute
- Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7
- (2016) Masaki Shiota et al. JNCI-Journal of the National Cancer Institute
- Hypertension and risk of prostate cancer: a systematic review and meta-analysis
- (2016) Zhen Liang et al. Scientific Reports
- Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension
- (2015) Alessandra Mileni Versuti Ritter et al. AMERICAN JOURNAL OF HYPERTENSION
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
- (2014) Masis Isikbay et al. Hormones & Cancer
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer
- (2012) Masaki Shiota et al. ENDOCRINE-RELATED CANCER
- Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
- (2011) Masaki Shiota et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Association of a Mineralocorticoid Receptor Gene Polymorphism With Hypertension in a Spanish Population
- (2009) Fernando Martinez et al. AMERICAN JOURNAL OF HYPERTENSION
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now